Share on LinkedInShare on LinkedIn

ARTICLE · 24 NOVEMBER 2021

Opioids: State Attorney General Marketing Enforcement Under Attack?

Kelley Drye & Warren LLP
Kelley Drye & Warren LLP
Contributor
Kelley Drye & Warren LLP

Kelley Drye & Warren LLP

About Kelley Drye We’re focused—in key areas of the law and on the nuances of each matter—to help...

View firm profile
Explore more from Kelley Drye & Warren LLP

November has been an active month in the years-long litigation of opioid manufacturers — and it hasn't been good for the theories put forth by Attorneys General and local governments.

United StatesMedia, Telecoms, IT, Entertainment

November has been an active month in the years-long litigation of opioid manufacturers — and it hasn't been good for the theories put forth by Attorneys General and local governments.  On November 1, Orange County Judge Peter Wilson, in litigation brought by Orange, Santa Clara, and Los Angeles Counties, along with the City of Oakland, ruled completely in favor of the defendants, several opioid manufacturers.  And then on November 9, the Oklahoma Supreme Court overturned the $475 million verdict against opioid manufacturer Johnson & Johnson.  Does this signal a weakening of state and local government authority to pursue these actions?  Not likely.

It's important to take a step back and look at the underlying theories of these cases.  While the thousands of governmental actions have been brought to address a public health crisis, at their core the actions against opioid manufacturers are largely based on theories that are marketing/advertising claims.  In essence,

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from